T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Dycom Industries
DY
$12.3B
| $1.55M | ﹤0.01% |
17,228
-3,125
| -15% | -$236K |
|
|
TUP
1577
DELISTED
Tupperware Brands Corporation
TUP
| $1.54M | ﹤0.01% |
27,428
+3,010
| +12% | +$172K |
|
1578
Bank OZK
OZK
$5.7B
| $1.54M | ﹤0.01% |
41,062
+4,462
| +12% | +$176K |
|
1579
TriNet
TNET
$3.22B
| $1.53M | ﹤0.01% |
73,500
-4,700
| -6% | -$86.1K |
|
1580
Avista
AVA
$3.24B
| $1.52M | ﹤0.01% |
33,995
+265
| +0.8% | +$10.9K |
|
|
DFT
1581
DELISTED
DuPont Fabros Technology Inc.
DFT
| $1.51M | ﹤0.01% |
31,864
+303
| +1% | +$13K |
|
1582
WaFd
WAFD
$2.81B
| $1.5M | ﹤0.01% |
61,860
+8,200
| +15% | +$197K |
|
1583
The Greenbrier Companies
GBX
$1.42B
| $1.49M | ﹤0.01% |
51,070
+5,500
| +12% | +$158K |
|
1584
MDU Resources
MDU
$4.27B
| $1.48M | ﹤0.01% |
162,619
+18,217
| +13% | +$148K |
|
|
INSY
1585
DELISTED
Insys Therapeutics, Inc.
INSY
| $1.48M | ﹤0.01% |
114,660
-25,000
| -18% | -$364K |
|
1586
Sensient Technologies
SXT
$5.53B
| $1.48M | ﹤0.01% |
20,819
+3,519
| +20% | +$238K |
|
1587
SITE Centers
SITC
$158M
| $1.48M | ﹤0.01% |
63,243
-12,151
| -16% | -$274K |
|
|
VVC
1588
DELISTED
Vectren Corporation
VVC
| $1.47M | ﹤0.01% |
27,867
+366
| +1% | +$18.3K |
|
|
HDS
1589
DELISTED
HD Supply Holdings, Inc.
HDS
| $1.46M | ﹤0.01% |
42,002
+4,161
| +11% | +$142K |
|
1590
Rithm Capital
RITM
$5.79B
| $1.46M | ﹤0.01% |
105,448
-16,827
| -14% | -$216K |
|
|
NRF
1591
DELISTED
NorthStar Realty Finance Corp.
NRF
| $1.45M | ﹤0.01% |
126,918
+29,200
| +30% | +$375K |
|
1592
Madison Square Garden
MSGS
$9.94B
| $1.45M | ﹤0.01% |
11,752
-416
| -3% | -$48.8K |
|
|
BEAV
1593
DELISTED
B/E Aerospace Inc
BEAV
| $1.45M | ﹤0.01% |
31,292
-5,293
| -14% | -$253K |
|
|
TECD
1594
DELISTED
Tech Data Corp
TECD
| $1.44M | ﹤0.01% |
20,090
-50
| -0.2% | -$3.63K |
|
1595
ITT
ITT
$19.4B
| $1.44M | ﹤0.01% |
45,095
+8,800
| +24% | +$316K |
|
1596
Healthcare Realty
HR
$6.58B
| $1.44M | ﹤0.01% |
44,510
-4
| -0% | -$120 |
|
1597
Jabil
JBL
$38.8B
| $1.44M | ﹤0.01% |
77,715
| – | – |
|
|
EXTN
1598
DELISTED
Exterran Corporation
EXTN
| $1.43M | ﹤0.01% |
111,449
-1,200
| -1% | -$16.6K |
|
|
UFS
1599
DELISTED
DOMTAR CORPORATION (New)
UFS
| $1.42M | ﹤0.01% |
40,619
| – | – |
|
|
VISN
1600
Vistance Networks Inc
VISN
$2.62B
| $1.42M | ﹤0.01% |
45,790
+5,675
| +14% | +$168K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.